Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>In addition to favorable effects on glucose control and cardiovascular outcomes, treatment with empagliflozin was associated with meaningful reductions in adverse renal outcomes.</p>

Empagliflozin Improves Renal Outcomes in Type 2 Diabetes